Your browser doesn't support javascript.
loading
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease.
Ahmad, Rawaha; Postnov, Andrey; Bormans, Guy; Versijpt, Jan; Vandenbulcke, Mathieu; Van Laere, Koen.
Afiliação
  • Ahmad R; Department of Imaging & Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven and University Hospitals Leuven, Leuven, Belgium. Rawaha.ahmad@uzleuven.be.
  • Postnov A; Division of Nuclear Medicine, University Hospital Leuven, Herestraat 49 E901, 3000, Leuven, Belgium. Rawaha.ahmad@uzleuven.be.
  • Bormans G; Department of Imaging & Pathology, Nuclear Medicine and Molecular Imaging, KU Leuven and University Hospitals Leuven, Leuven, Belgium.
  • Versijpt J; National Research Nuclear University MEPhI, Moscow, Russia.
  • Vandenbulcke M; Laboratory for Radiopharmacy, KU Leuven, Leuven, Belgium.
  • Van Laere K; Department of Neurology, University Hospital Brussels, Brussels, Belgium.
Eur J Nucl Med Mol Imaging ; 43(12): 2219-2227, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27488857
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Encéfalo / Placa Amiloide / Receptor CB2 de Canabinoide / Doença de Alzheimer / Modelos Neurológicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinolinas / Encéfalo / Placa Amiloide / Receptor CB2 de Canabinoide / Doença de Alzheimer / Modelos Neurológicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article